Merck drops Karo Bio compound
The lead compound in Merck and Karo Bio's selective oestrogen receptor modulator collaboration has been dropped after toxicity emerged preclinical tests.
The lead compound in Merck and Karo Bio's selective oestrogen receptor modulator collaboration has been dropped after toxicity emerged preclinical tests.
UK-based Astex Technology has revealed that it has signed a structure-based drug discovery agreement with Japan's Fujisawa.
Clariant has announced plans to establish a Technology Centre in Germany that will support the pharmaceutical industry in the commercialisation of new drugs.
A new-generation smallpox vaccine developed by Acambis may be less neurovirulent than a rival registered in the USA, while still providing equivalent immunogenicity.
Researchers have uncovered evidence that the first time that neurotoxic peptide assemblies known as ADDLs are responsible for Alzheimer's disease in humans.